Cambridge, UK – 17 October 2016 – Bespak, a full-service drug delivery partner specialising in innovative medical devices, today announces the launch of the Syrina™ AR 2.25 auto injector. This innovative auto-injector is the latest addition to the VapourSoft™-powered Syrina range and is suitable for delivering volumes of up to 2ml using a standard 2.25ml pre-filled syringe. The Syrina AR 2.25 provides patients with a fully-automatic two-step, compact device for the self-administration of viscous drug formulations.
Using Bespak’s proven proprietary compact energy source, VapourSoft, Syrina AR 2.25 is able to deliver 2ml of viscous drug solutions smoothly and safely in less than 15 seconds. Designed with a hidden needle, Syrina AR 2.25 offers automatic needle insertion and retraction, as well as drug delivery with a single push-on-skin operation. Syrina AR 2.25 has been tailored specifically for higher viscosities while still enabling the safe use of glass syringes.
Using VapourSoft at its core allows a compact design and, with quiet operation, provides a discrete solution for patients. Syrina AR 2.25 is clinical trial ready, enabling a fast track implementation process once paired with a specific drug formulation.
Keyvan Djamarani, Managing Director, Bespak commented: “There is increasing demand from the industry for innovative drug delivery devices that enable self-administration of the latest challenging drug formulations. As viscosities and dosage volumes both increase, the ability to safely and quickly deliver the dose remain paramount. For the first time, Syrina AR 2.25 incorporates our revolutionary compact energy source, VapourSoft, into a fully-automatic compact auto-injector device, designed specifically to meet the industry’s most demanding needs.”
Other injection devices in Bespak’s Syrina range include the Syrina Micro, Syrina Mini, Syrina S and Syrina AS. Read more about the Syrina range and how it is being adopted by the industry here.
